Search

Displaying results 9991 - 10000 of 10000 in total
  1. Drug

    2G7

    go.drugbank.com/drugs/DB18589
    Experimental

    2G7 is an anti-TGF-beta monoclonal antibody developed by Genentech.

  2. Drug

    Dilanubicel

    go.drugbank.com/drugs/DB18722
    Investigational

    Dilanubicel consists of ex vivo expanded hematopoietic stem and progenitor cells.

  3. Drug

    MGD-024

    go.drugbank.com/drugs/DB17265
    Investigational

    MGD-024 is an anti-CD123/anti-CD3 bispecific DART molecule.

  4. Drug

    Norvaline

    go.drugbank.com/drugs/DB04185
    Investigational

    Norvaline is an isomer of the more common amino acid valine.

  5. Drug

    Bacteriochlorophyll A

    go.drugbank.com/drugs/DB01853
    Experimental

    A specific bacteriochlorophyll that is similar in structure to CHLOROPHYLL A.

  6. Drug

    RO-4987655

    go.drugbank.com/drugs/DB12933
    Investigational

    RO4987655 has been used in trials studying the treatment of Neoplasms.

  7. Drug

    Nimustine

    go.drugbank.com/drugs/DB13069
    Investigational

    Nimustine has been used in trials studying the treatment of Glioblastoma.

  8. Drug

    Romifidine

    go.drugbank.com/drugs/DB11543
    ExperimentalVet approved

    Romifidine is a veterinary drug utilized as a sedative primarily in large animals, most frequently horses. It is also used less commonly in a wide variety of other animal species. … This drug's chemical structure closely resembles that of clonidine, however, romifidine is not approved for use in humans.

  9. Drug

    TS-104

    go.drugbank.com/drugs/DB33943
    Experimental

    in Subjects With Select Advanced Solid Tumors). … TS-104 is under investigation in clinical trial NCT07814248 (A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy

  10. Drug

    NB-001

    go.drugbank.com/drugs/DB12716
    Investigational

    NB-001 has been investigated for the treatment of Recurrent Herpes Labialis.